13 false false false false false false false false false false true false false false false false false 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 13756774 2024-04-01 2025-03-31 13756774 2025-03-31 13756774 2024-03-31 13756774 2023-04-01 2024-03-31 13756774 2024-03-31 13756774 2023-03-31 13756774 core:PlantMachinery 2024-04-01 2025-03-31 13756774 core:FurnitureFittings 2024-04-01 2025-03-31 13756774 bus:Director5 2024-04-01 2025-03-31 13756774 core:PlantMachinery 2024-03-31 13756774 core:FurnitureFittings 2024-03-31 13756774 core:PlantMachinery 2025-03-31 13756774 core:FurnitureFittings 2025-03-31 13756774 core:WithinOneYear 2025-03-31 13756774 core:WithinOneYear 2024-03-31 13756774 core:ShareCapital 2025-03-31 13756774 core:ShareCapital 2024-03-31 13756774 core:OtherReservesSubtotal 2025-03-31 13756774 core:OtherReservesSubtotal 2024-03-31 13756774 core:RetainedEarningsAccumulatedLosses 2025-03-31 13756774 core:RetainedEarningsAccumulatedLosses 2024-03-31 13756774 core:PlantMachinery 2024-03-31 13756774 core:FurnitureFittings 2024-03-31 13756774 bus:Director1 2024-04-01 2025-03-31 13756774 bus:SmallEntities 2024-04-01 2025-03-31 13756774 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 13756774 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 13756774 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13756774 bus:FullAccounts 2024-04-01 2025-03-31 13756774 core:ComputerEquipment 2024-04-01 2025-03-31 13756774 core:Vehicles 2024-04-01 2025-03-31 13756774 core:ComputerEquipment 2024-03-31 13756774 core:Vehicles 2024-03-31 13756774 core:ComputerEquipment 2025-03-31 13756774 core:Vehicles 2025-03-31
COMPANY REGISTRATION NUMBER: 13756774

Sania Tx Ltd (Previously: Sania Rx Ltd)

Filleted Unaudited Financial Statements

31 March 2025

Sania Tx Ltd (Previously: Sania Rx Ltd)

Financial Statements

Year ended 31 March 2025

Contents | Page

Statement of financial position | 1

Notes to the financial statements | 3

Sania Tx Ltd (Previously: Sania Rx Ltd)

Statement of Financial Position

31 March 2025

| 2025 | 2024
Note | £ | £

Fixed assets

Tangible assets | 5 | 368,428 | 267,765

Current assets

Debtors | 6 | 720,058 | 158,340
Cash at bank and in hand | 42,026 | 117,006
| --------- | ---------
| 762,084 | 275,346

Creditors: amounts falling due within one year | 7 | 400,045 | 119,112
| --------- | ---------
Net current assets | 362,039 | 156,234
| --------- | ---------
Total assets less current liabilities | 730,467 | 423,999
| --------- | ---------
Net assets | 730,467 | 423,999
| --------- | ---------

Capital and reserves

Called up share capital | 1 | 1
Other reserves | 6,098,011 | 3,530,837
Profit and loss account | ( 5,367,545) | ( 3,106,839)
| ------------ | ------------
Shareholders funds | 730,467 | 423,999
| ------------ | ------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .

Sania Tx Ltd (Previously: Sania Rx Ltd)

Statement of Financial Position (continued)

31 March 2025
These financial statements were approved by the board of directors and authorised for issue on 14 January 2026 , and are signed on behalf of the board by:

Mr J Korff
Director

Company registration number: 13756774

Sania Tx Ltd (Previously: Sania Rx Ltd)

Notes to the Financial Statements

Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Waterfront Buidling Manbre Wharf, Manbre Road, London, W6 9RH, United Kingdom. On 29 April 2025, Sania Rx Ltd changed its name to Sania Tx Ltd.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The accounts have been prepared on a going concern basis which relies upon the continuing support of the investors.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to the profit and loss account.
Tangible assets
Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

| Laboratory equipment | - | 20% straight line
| Office equipment | - | 33% straight line
| Computer equipment | - | 33% straight line
| Cycle to work assets | - | 20% straight line

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 13 (2024: 10 ).
5. Tangible assets

| Laboratory equipment | Office equipment | Computer equipment | Cycle to work assets | Total
| £ | £ | £ | £ | £
Cost |  |  |  |  |
At 1 April 2024 | 349,168 | 13,936 | 26,508 | 2,946 | 392,558
Additions | 174,410 | 25,260 | 10,314 | – | 209,984
| --------- | -------- | -------- | ------- | ---------
At 31 March 2025 | 523,578 | 39,196 | 36,822 | 2,946 | 602,542
| --------- | -------- | -------- | ------- | ---------
Depreciation |  |  |  |  |
At 1 April 2024 | 102,775 | 6,758 | 14,493 | 767 | 124,793
Charge for the year | 91,130 | 6,650 | 10,952 | 589 | 109,321
| --------- | -------- | -------- | ------- | ---------
At 31 March 2025 | 193,905 | 13,408 | 25,445 | 1,356 | 234,114
| --------- | -------- | -------- | ------- | ---------
Carrying amount |  |  |  |  |
At 31 March 2025 | 329,673 | 25,788 | 11,377 | 1,590 | 368,428
| --------- | -------- | -------- | ------- | ---------
At 31 March 2024 | 246,393 | 7,178 | 12,015 | 2,179 | 267,765
| --------- | -------- | -------- | ------- | ---------

6. Debtors

| 2025 | 2024
| £ | £
Other debtors | 720,058 | 158,340
| --------- | ---------

7. Creditors: amounts falling due within one year

| 2025 | 2024
| £ | £
Trade creditors | 272,455 | 106,647
Social security and other taxes | 30,474 | –
Other creditors | 97,116 | 12,465
| --------- | ---------
| 400,045 | 119,112
| --------- | ---------

8. Controlling party
The ultimate parent company is Sania Therapeutics, Inc , a company registered in Delaware, USA. The registered address of the ultimate controlling party is: C/O Sania Tx Ltd, Waterfront Building, Manbre Wharf, London, W6 9RH .